Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese HSK 1 – For Medical Students & Physicians A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languages — free forever. Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese. By Bernd Sebastian Kamps and Andrea Melis

Parkinson's Disease

Free Subscription Articles published in Nat Med Retrieve available abstracts of 26 articles: HTML format

Single Articles

April 2026
1. MENOZZI E, Ren Y, Geiger M, Macnaughtan J, et al
   Microbiome signature of Parkinson's disease in healthy and genetically at-risk individuals.
   Nat Med. 2026 Apr 20. doi: 10.1038/s41591-026-04318.
   PubMed     Abstract available
   
   
   March 2026
2. MABROUK OS, Tichler B, Arnold HM, Thoma EC, et al
   LRRK2-targeting antisense oligonucleotide in Parkinson's disease: a phase 1 randomized controlled trial.
   Nat Med. 2026 Mar 24. doi: 10.1038/s41591-026-04262.
   PubMed     Abstract available
   
   
   
3. BOLSEWIG K, Bellomo G, Hok-A-Hin YS, Al Idrissi I, et al
   A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders.
   Nat Med. 2026;32:1073-1084.
   PubMed     Abstract available
   
   
   September 2025
4. ALI M, Erabadda B, Chen Y, Xu Y, et al
   Author Correction: Shared and disease-specific pathways in frontotemporal dementia and Alzheimer's and Parkinson's diseases.
   Nat Med. 2025 Sep 2. doi: 10.1038/s41591-025-03970.
   PubMed    
   
   
   August 2025
5. SHVETCOV A, Johnson ECB, Winchester LM, Walker KA, et al
   APOE epsilon4 carriers share immune-related proteomic changes across neurodegenerative diseases.
   Nat Med. 2025;31:2590-2601.
   PubMed     Abstract available
   
   
   
6. IMAM F, Saloner R, Vogel JW, Krish V, et al
   The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging.
   Nat Med. 2025;31:2556-2566.
   PubMed     Abstract available
   
   
   July 2025
7. ALI M, Erabadda B, Chen Y, Xu Y, et al
   Shared and disease-specific pathways in frontotemporal dementia and Alzheimer's and Parkinson's diseases.
   Nat Med. 2025 Jul 15. doi: 10.1038/s41591-025-03833.
   PubMed     Abstract available
   
   
   June 2025
8. HEALEY N
   Stem cell therapies advance in Parkinson's disease and beyond.
   Nat Med. 2025 Jun 4. doi: 10.1038/d41591-025-00036.
   PubMed    
   
   
   April 2025
9. O'LEARY K
   Progress with stem cell therapy in Parkinson's disease.
   Nat Med. 2025 Apr 30. doi: 10.1038/d41591-025-00029.
   PubMed    
   
   
   February 2025
10. SOTO C, Mollenhauer B, Hansson O, Kang UJ, et al
    Toward a biological definition of neuronal and glial synucleinopathies.
    Nat Med. 2025;31:396-408.
    PubMed     Abstract available
    
    
    January 2025
11. MOREAU C, Odou P, Labreuche J, Demailly A, et al
    Intracerebroventricular anaerobic dopamine in Parkinson's disease with L-dopa-related complications: a phase 1/2 randomized-controlled trial.
    Nat Med. 2025 Jan 7. doi: 10.1038/s41591-024-03428.
    PubMed     Abstract available
    
    
    
12. CASTRO-ALDRETE L, Huc M, Domingos J, Vaudano E, et al
    Using a sex- and gender-informed lens to enhance care in Parkinson's disease.
    Nat Med. 2025 Jan 3. doi: 10.1038/s41591-024-03363.
    PubMed    
    
    
    October 2024
13. PAGANO G, Monnet A, Reyes A, Ribba B, et al
    Sustained effect of prasinezumab on Parkinson's disease motor progression in the open-label extension of the PASADENA trial.
    Nat Med. 2024 Oct 8. doi: 10.1038/s41591-024-03270.
    PubMed     Abstract available
    
    
    September 2024
14. EIJSVOGEL P, Misra P, Concha-Marambio L, Boyd JD, et al
    Target engagement and immunogenicity of an active immunotherapeutic targeting pathological alpha-synuclein: a phase 1 placebo-controlled trial.
    Nat Med. 2024;30:2631-2640.
    PubMed     Abstract available
    
    
    August 2024
15. OEHRN CR, Cernera S, Hammer LH, Shcherbakova M, et al
    Chronic adaptive deep brain stimulation versus conventional stimulation in Parkinson's disease: a blinded randomized feasibility trial.
    Nat Med. 2024 Aug 19. doi: 10.1038/s41591-024-03196.
    PubMed     Abstract available
    
    
    April 2024
16. MULIYIL S
    Repurposing a diabetes drug to treat Parkinson's disease.
    Nat Med. 2024 Apr 20. doi: 10.1038/d41591-024-00026.
    PubMed    
    
    
    
17. PAGANO G, Taylor KI, Anzures Cabrera J, Simuni T, et al
    Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson's disease.
    Nat Med. 2024;30:1096-1103.
    PubMed     Abstract available
    
    
    January 2024
18. 
    Wearable robot helps man with Parkinson's disease to walk.
    Nat Med. 2024 Jan 15. doi: 10.1038/s41591-023-02756.
    PubMed    
    
    
    
19. KIM J, Porciuncula F, Yang HD, Wendel N, et al
    Soft robotic apparel to avert freezing of gait in Parkinson's disease.
    Nat Med. 2024 Jan 5. doi: 10.1038/s41591-023-02731.
    PubMed     Abstract available
    
    
    November 2023
20. MIZRAHI-KLIGER A, Ganguly K
    Spinal stimulation for unfreezing gait in Parkinson's disease.
    Nat Med. 2023 Nov 6. doi: 10.1038/s41591-023-02604.
    PubMed    
    
    
    
21. MILEKOVIC T, Moraud EM, Macellari N, Moerman C, et al
    A spinal cord neuroprosthesis for locomotor deficits due to Parkinson's disease.
    Nat Med. 2023 Nov 6. doi: 10.1038/s41591-023-02584.
    PubMed     Abstract available
    
    
    August 2023
22. QUADALTI C, Palmqvist S, Hall S, Rossi M, et al
    Clinical effects of Lewy body pathology in cognitively impaired individuals.
    Nat Med. 2023;29:1964-1970.
    PubMed     Abstract available
    
    
    July 2023
23. SCHALKAMP AK, Peall KJ, Harrison NA, Sandor C, et al
    Wearable movement-tracking data identify Parkinson's disease years before clinical diagnosis.
    Nat Med. 2023 Jul 3. doi: 10.1038/s41591-023-02440.
    PubMed     Abstract available
    
    
    June 2023
24. OKUZUMI A, Hatano T, Matsumoto G, Nojiri S, et al
    Propagative alpha-synuclein seeds as serum biomarkers for synucleinopathies.
    Nat Med. 2023;29:1448-1455.
    PubMed     Abstract available
    
    
    April 2023
25. O'LEARY K
    Biomarker study a game-changer for Parkinson's disease.
    Nat Med. 2023 Apr 27. doi: 10.1038/d41591-023-00039.
    PubMed    
    
    
    March 2023
26. O'LEARY K
    Ultrasound-based treatment for Parkinson's disease.
    Nat Med. 2023 Mar 6. doi: 10.1038/d41591-023-00026.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum